Demonstrating the Economic Value of Minimally Invasive Spinal Surgery (MIS) on the iPad
Economic and clinical value is now imperative in discussions with a wide array of stakeholders, from physicians to hospital administrators and payers. However, the evidence from these types of studies can be difficult to present if the audience lacks an understanding of health economics. And so, Medtronic’s commercial team needed a way to present complex data in a clear and intuitive format that would plainly communicate key messages to non-experts.
After conducting a micro-costing study at two hospitals in Italy, Medtronic’s team turned to Certara’s BaseCase platform to build an app that would communicate the potential cost savings and reduced length of stay timelines to key stakeholders in various markets.
Upon launching the app, it was found that the clear and simple ways in which the value messages were communicated not only made the data and evidence easily understandable, but also kept audiences engaged much longer than other traditional collateral. Internally, the success of the app also helped raise awareness about the effectiveness of MIS. And the flexibility of the BaseCase platform enabled the team to rapidly act on feedback from field teams, with new prototypes taking less than one day to get in the hands of field teams.
Headquartered in Minneapolis, Minnesota, Medtronic, lnc. is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic has over 100,000 employees in 120 different countries, and 2017 revenues exceeded $30 billion. Medtronic’s Spinal Business (based in Memphis, Tennessee) is the global market leader and committed to advance the treatment of spinal conditions.
